Activation of this pathway has been associated with the induction of doxorubicin resistance in ALL cell lines[75], though further studies are needed to fully elucidate the relationship between altered TNFα expression and signaling and clinical outcomes for patients with ALL. This evidence concerns the gene TNF and acute lymphoblastic leukemia.